HOME >> MEDICINE >> NEWS
Montreal researchers identify defects of immune cells

Montral -- Researchers at Universit de Montral and the Institut de recherches cliniques de Montral (IRCM) have successfully identified a defective immune cell population that determines susceptibility to candidiasis, a common and often debilitating infection in individuals infected with the human immunodeficiency virus (HIV). These findings, revealed using a model of candidiasis in transgenic mice expressing HIV developed by the same research group, represents a milestone in developing a treatment for the infection and, eventually, preventing it. They are described in an article of the July 1st issue of The Journal of Immunology.

Oral and esophageal Candida albicans infections, which often affect individuals infected with HIV, may limit food consumption and lead to weight loss, threatening patients' general health and well-being. Of added concern, treatment of candidiasis in these patients is often complicated by strains of Candida albicans resistant to conventional antifungal therapies. The research project was carried out jointly by Dr. Louis de Repentigny, Director of the Medical Mycology Laboratory and Professor in the Department of Microbiology and Immunology at the Faculty of Medicine of Universit de Montral, and at CHU Sainte-Justine, and Dr. Paul Jolicoeur, Director of the Molecular Biology Research Unit at the Institut de recherches cliniques de Montral (IRCM), researcher in the Department of Microbiology and Immunology at the Faculty of Medicine of Universit de Montral, associate member of the McGill University Faculty of Medicine and holder of the Canada Research Chair on Infectious and Parasitic Diseases and Dr Zaher Hanna, Associate Director in the same Unit, researcher in the Department of Medicine at the Faculty of Medicine of Universit de Montral, associate member of the McGill University Division of Experimental Medicine.

Drs de Repentigny, Jolicur and Hanna have for the first time succeeded in demonstrating that defective CD4+
'"/>

Contact: Sophie Langlois
sophie.langlois@umontreal.ca
514-343-7704
University of Montreal
21-Jun-2006


Page: 1 2

Related medicine news :

1. Montreal researchers make a major strategic breakthrough in controling the AIDS virus
2. As Montreal Conference considers deforestation issues, ESA presents space solution
3. ESA participating in UNs Montreal summit working for a better atmosphere
4. Stanford researchers find culprit in aging muscles that heal poorly
5. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
6. Penn researchers discover novel pathway for increasing good cholesterol
7. Theory of facial aging gets a facelift from UT Southwestern researchers
8. UIC researchers to develop new drugs to fight bioterrorism
9. UQ researchers discover some of the oldest forms of life
10. U of M researchers discover new method to combat HIV
11. U of M researchers assess effectiveness of computerized physician order entry system

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Montreal researchers identify defects immune cells

(Date:5/23/2013)... Steven Reinberg HealthDay Reporter , , THURSDAY, May ... heartburn may be at increased risk for cancers of ... smoke or drink alcohol, a new study says. ... cancers while prescription medications such as Prilosec, Nexium and ... a controversy about whether heartburn contributes to cancers of ...
(Date:5/23/2013)... of older adults with dementia are less stressed ... dementia patients receive adult day services (ADS), according ... with and care for someone with dementia can ... professor and head, human development and family studies. ... provide caregivers with a much-needed break that can ...
(Date:5/23/2013)... YORK (May 23, 2013) -- Little is known about ... why response to treatments varies between patients. Now, a ... University Medical Center and SUNY Downstate Medical Center has ... asthma, showing that it is very different from other ... Medicine , reveals that an over-active gene linked in ...
(Date:5/23/2013)... researchers at Henry Ford Hospital found "substantial evidence" that ... spinal cord could hold the key to better functional ... new hope to those who suffer stroke, the leading ... victims recover some ability to voluntarily use their hands ... weakness on one side of their bodies, while a ...
(Date:5/23/2013)... It is Go Classy Tours / Caribbean Hideaways' ... Spa , a luxury nudist resort located in the Rivera ... International Naked Painting Party. Hidden Beach is a perfect location ... Hot Tub, Nude Bars & Nightclub and Nude Dinning. ... August 15th and go through August 18th, with the actual ...
Breaking Medicine News(10 mins):Health News:Chronic Heartburn May Raise Odds for Throat Cancer: Study 2Health News:Adult day services for dementia patients provide stress relief to family caregivers 2Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 2Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 3Health News:Regenerating spinal cord fibers may be treatment for stroke-related disabilities 2Health News:Regenerating spinal cord fibers may be treatment for stroke-related disabilities 3Health News:Hidden Beach, the Only Luxurious All-inclusive Nudist Resort in the Mexican Caribbean, to Host Social Exposure's Naked Painting Party, Announces Go Classy Tours 2
(Date:5/23/2013)... , May 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of novel ... as primary biliary cirrhosis, today announced that ... Officer, will present at the Deutsche Bank Securities 38th ... on Wednesday, May 29, 2013 at 4:10 p.m. ...
(Date:5/23/2013)... , May 23, 2013  Omeros Corporation (NASDAQ: ... Investigational New Drug Application (IND) to evaluate OMS824 ... U.S. Food and Drug Administration (FDA). OMS824 selectively ... areas of the brain linked to a wide ... disease and schizophrenia. OMS824 has shown promising results ...
(Date:5/23/2013)...  MedVantx, Inc., the company that has pioneered a ... the Company has completed a major expansion of its ... and the upgrade of its systems to offer a ... specialty home delivery pharmacy in Sioux Falls, ... physicians, health systems and payors novel distribution services, as ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3
Cached News: